Malaria Vaccines Market Emerging Technologies and Global Forecast Insights through 2031 WRAIR, Sanaria, BioNTech, Nobelpharma.

Global Malaria Vaccines market is expected to grow at a CAGR Of 31.85% during the forecast period 2024-2031.

Malaria Vaccines Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/malaria-vaccines-market?rk

Malaria vaccines are immunizations developed to prevent malaria, a life-threatening disease caused by Plasmodium parasites transmitted through mosquito bites. The RTS,S/AS01 (Mosquirix) vaccine is the first malaria vaccine approved for use, offering partial protection against the disease. Efforts to improve vaccine efficacy continue, with new candidates in clinical trials. Malaria remains a major global health challenge, particularly in tropical and subtropical regions. Government initiatives and global vaccination programs are driving the demand for malaria vaccines.

List of the Key Players in the Malaria Vaccines Market:

GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria, BioNTech, Nobelpharma, CellFree Sciences, Sumaya Biotech, VLP Therapeutics LLC, Bharat Biotech, Serum Institute of India, Novavax, Kenya medical research institute.

Industry Development:

In October 2021, the World Health Organization (WHO) recommended the Mosquirix vaccine for widespread use in children, making it the first malaria vaccine to receive such approval. This milestone marked a significant advancement in the fight against malaria, particularly in regions with high transmission rates. Mosquirix, developed by GlaxoSmithKline (GSK), has shown efficacy in reducing severe malaria cases among young children, who are the most vulnerable to the disease. The WHO's recommendation was based on large-scale pilot programs in Ghana, Kenya, and Malawi, demonstrating the vaccine's safety and effectiveness. This approval represents a crucial step toward reducing malaria-related mortality and improving child health globally.

Market Dynamics:

The rising incidence of malaria cases globally is driving the market growth over the forecast period. According to the World Health Organization (WHO), around 241 million malaria cases were recorded globally in 2022, with 627,000 deaths. The African region continues to bear the highest malaria burden, accounting for 95% of cases and 96% of deaths in 2020, with approximately 260,000 African children under five succumbing to the disease annually. The first recombinant malaria vaccine, RTS,S, was developed by GlaxoSmithKline (GSK) and Malaria Vaccine Initiatives (MVI) with funding from the Gates Family Foundation and was recommended for widespread use in children by WHO in October 2021. Currently, the most effective malaria vaccine is R21/Matrix-M, with a 77% efficacy rate, surpassing WHO's 75% effectiveness benchmark. Developed through a collaboration between the University of Oxford, the London School of Hygiene and Tropical Medicine, the Kenya Medical Research Institute, the Serum Institute of India, Novavax, and the Institute of Research in Health Sciences in Nanoro, Burkina Faso, the R21 vaccine contains a higher proportion of the circumsporozoite protein (CSP) antigen than RTS,S, enhancing its effectiveness.

For Direct Purchase: https://www.datamintelligence.com/buy-now-page?report=malaria-vaccines-market?rk

Growth Forecast Projected:

The Global Malaria Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Malaria Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/malaria-vaccines-market?rk

Segment Covered in the Malaria Vaccines Market:

By Type of Infectious Agents: Plasmodium Falciparum, Species of Anopheles, P. vivax, P. malaria, Others.

By Type of Vaccines: Erythrocytic, Pre erythrocytic, Multi antigen, Others.

By End User: Hospitals, Speciality Clinics, Retail Pharmacy, Others.

Regional Analysis for Malaria Vaccines Market:

The regional analysis of the Malaria Vaccines Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/malaria-vaccines-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Malaria Vaccines market?

➠ Who are the leading manufacturers in the global Malaria Vaccines industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Malaria Vaccines industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Malaria Vaccines market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/malaria-vaccines-market?rk

Lichen Sclerosus Treatment Market: https://www.datamintelligence.com/research-report/lichen-sclerosus-treatment-market?rk

Acute Otitis Media Treatment Market: https://www.datamintelligence.com/research-report/acute-otitis-media-treatment-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.